Calix (ASX:CXL) secured a three-year contract for the supply of magnesium hydroxide water treatment products to a US customer, according to a Friday filing with the Australian bourse.
The contract is expected to generate up to AU$10 million in additional annual product and services revenue and includes options for a further two years, the filing said.
First revenues are expected in the first quarter of 2026, per the filing.
Shares rose nearly 12% in midday trade on Friday.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments